Spots Global Cancer Trial Database for spliceosome mutation
Every month we try and update this database with for spliceosome mutation cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome | NCT02060409 | Myelodysplastic... | spliceosome | 17 Years - 90 Years | Samsung Medical Center | |
| Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM) | NCT04447651 | Metastatic Soli... SF3B1 Gene Muta... Spliceosome Mut... U2AF1 Gene Muta... SRSF2 Gene Muta... | Recommendation ... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
